Xpo, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NYSE
Capital Research Global Investors has disclosed beneficial ownership of 7.0% of XPO, Inc.'s common stock, holding 8,271,824 shares.
NYSE
MFN Partners, through its associated entities, has disclosed a beneficial ownership of 9,869,691 shares, representing 8.4% of XPO, Inc.'s common stock as of June 30, 2026.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 10.4% of XPO, Inc.'s common stock as of May 31, 2026.
NYSE
Invesco Ltd. has filed an amended Schedule 13G reporting beneficial ownership of 4,831,614 shares of XPO Inc. common stock.
NYSE
Vanguard Capital Management has reported beneficial ownership of 5.08% of XPO Inc.'s common stock as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in XPO Inc. following an internal organizational realignment.
NYSE
Capital Research Global Investors has disclosed a 9.5% beneficial ownership stake in XPO, Inc. common stock as of December 31, 2025.
NYSE
Capital World Investors has filed an Amendment No. 3 to Schedule 13G, reporting a 9.3% beneficial ownership in XPO, Inc. common stock.
NYSE
Invesco Ltd. has reported a 5.3% beneficial ownership stake in XPO Inc.'s common stock, held in the ordinary course of business.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 8.8% of XPO, Inc.'s common stock as of June 30, 2025.
NYSE
Capital World Investors has filed an amended Schedule 13G, revealing a beneficial ownership of 8.3% of XPO, Inc.'s common stock as of March 31, 2025.
NYSE
Capital World Investors has filed an amended Schedule 13G, revealing a 6.7% beneficial ownership stake in XPO, Inc. as of December 31, 2024.
NYSE
BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 10.1% of XPO, Inc.'s common stock as of December 31, 2024.